Beta
Back to CVS.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
cash-flow-chart

CVS Cash Flow

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

In Q4'25, CVS's Operating Cash Flow reached $3.39B USD, marking a significant recovery from the modest $796M USD in Q3'25 and reflecting improved operational efficiency at year-end. Free Cash Flow for the same period stood at $2.61B USD, up substantially from $98M USD in the prior quarter, indicating stronger liquidity after capital expenditures. Over the period from Q1'23 to Q4'25, Operating Cash Flow exhibited volatility with peaks of $7.44B USD in Q1'23 and troughs of -$2.64B USD in Q4'23, followed by a general stabilization and upward trend in 2025, averaging around $2.5B USD annually. Free Cash Flow mirrored this pattern, declining sharply to -$3.55B USD in Q4'23 before rebounding to positive territory, with notable growth in Q1'25 ($3.81B USD) and Q4'25, underscoring CVS's ability to manage cash outflows amid fluctuating retail and healthcare demands. The bar chart highlights seasonal influences, particularly stronger flows in Q1 and Q4 quarters.